Article

Pan-cancer analysis identifies SEC11A as an immunological and prognostic biomarker

2022-11-03

Abstract excerpt

<h4>Objective: </h4> Limited evidence suggests a vital role for SEC11A in carcinogenesis. Our study conducted an integrated analysis on the molecular features and clinical relevance of SEC11A across pan-cancer based on multi-omics data. <h4>Materials and Methods:</h4> SEC11A expression was analyzed in 33 types of tumor and normal specimens utilizing transcriptome profiles from TCGA-GTEx project and protromic data...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 52bd7d4c-cfa8-568f-a4cd-5b1643ac664c
DOI: 10.21203/rs.3.rs-2145822/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Pan-cancer analysis identifies SEC11A as an immunological and prognostic biomarkerDOI 10.21203/rs.3.rs-2145822/v1Read

SEC61G Overexpression and DNA Amplification Correlates With Prognosis and Immune Cell Infiltration in Head and Neck Squamous Cell CarcinomaSemantic proximity Read

Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validationSemantic proximity Read

SEC61G Overexpression and DNA Amplification Correlates With Prognosis and Immune Cell Infiltration in Head and Neck Squamous Cell CarcinomaSemantic proximity Read

SEC61G regulates breast cancer cell proliferation and metastasis by affecting the Epithelial-Mesenchymal TransitionSemantic proximity Read

Comprehensive pan-cancer analysis identified SLC16A3 as a potential prognostic and diagnostic biomarkerSemantic proximity Read

SEC61 translocon gamma subunit is correlated with glycolytic activity, epithelial mesenchymal transition and the immune suppressive phenotype of lung adenocarcinoma.Semantic proximity Read

Pan-Cancer Analysis Reveals SOX2 as a Promising Prognostic and Immunotherapeutic Biomarker Across Various Cancer Types, Including Pancreatic CancerSemantic proximity Read

SEC61G assists EGFR -amplified glioblastoma to evade immune eliminationSemantic proximity Read

SEC61G identified as a prognostic biomarker of head and neck squamous cell carcinomaSemantic proximity Read

AHSA1 is a Prognostic Biomarker that Correlates with Macrophage Infiltration in Pan-CancerSemantic proximity Read

Pan-cancer analysis identifies SPEN mutation as a predictive biomarker with the efficacy of immunotherapy.Semantic proximity Read

ESCRT may function as a tumor biomarker, transitioning from pan-cancer analysis to validation within breast cancerSemantic proximity Read